| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSTL | Common Stock | Sale | -$149K | -3.85K | -1.85% | $38.65 | 205K | Feb 22, 2022 | By LLC | F1, F2, F3 |
| transaction | CSTL | Common Stock | Sale | -$97.7K | -2.5K | -2.22% | $39.09 | 110K | Feb 22, 2022 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F5 |
| transaction | CSTL | Common Stock | Sale | -$98.8K | -2.5K | -2.22% | $39.50 | 110K | Feb 22, 2022 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F6, F7 |
| transaction | CSTL | Common Stock | Sale | -$150K | -3.85K | -1.88% | $38.97 | 201K | Feb 23, 2022 | By LLC | F1, F3, F8 |
| transaction | CSTL | Common Stock | Sale | -$98K | -2.5K | -2.27% | $39.18 | 108K | Feb 23, 2022 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F5, F9 |
| transaction | CSTL | Common Stock | Sale | -$99.3K | -2.5K | -2.27% | $39.71 | 108K | Feb 23, 2022 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F7, F10 |
| Id | Content |
|---|---|
| F1 | The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted collectively by BioBrit, LLC (the "LLC"), The Annette E. Bradbury Irrevocable Descendants' Trust, and The Daniel M. Bradbury Irrevocable Descendants' Trust on November 30, 2021. |
| F2 | This transaction was executed in multiple trades at prices ranging from $38.170 to $39.000, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. |
| F4 | This transaction was executed in multiple trades at prices ranging from $39.000 to $39.180, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F6 | This transaction was executed in multiple trades at prices ranging from $39.180 to $39.810, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F8 | This transaction was executed in multiple trades at prices ranging from $38.885 to $39.050, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $39.050 to $39.370, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F10 | This transaction was executed in multiple trades at prices ranging from $39.375 to $40.020, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |